New Products, Partnerships, Discoveries
1. Imperial NHS and Luscii work on heart failure at-home monitoring
Imperial College Healthcare NHS Trust is working with remote healthcare innovator, Luscii to provide an at-home monitoring platform to support patients with heart failure.
2. Infermedica launches paediatrics AI pre-diagnostics solution
Infermedica, an AI-driven pre-diagnostics and care coordination platform – has launched a new paediatrics solution to enable preliminary diagnosis and triage of infants, toddlers and children.
3. AI cancer diagnosis platform receives FDA Breakthrough Device Designation
Ibex Medical Analytics, a specialist in AI-powered cancer diagnostics, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), which will help fast track the clinical review and regulatory approval of its platform.
4. Ada Health partners with Novartis to work on diagnosis for immunological diseases
The partnership will use Ada Health's AI-based platform to speed up the diagnosis of rare conditions.
5. Exscientia buys Allcyte to add patient sample testing to its AI platform
UK-based artificial intelligence pioneer Exscientia has made a play to stay at the forefront of the field, acquiring Austrian rival Allcyte with the help of its recent $525 million financing.
6. Research suggests Epic Sepsis Model is lacking in predictive power
A retrospective study in JAMA Internal Medicine finds that the model did not identify two-thirds of sepsis patients and frequently issued false alarms.
7. NHS to pilot blood test that identifies 50 types of cancer
The test uses machine learning to identify cancers including ovarian and some blood cancers before clinical signs emerge.
8. AliveCor Moves Toward Ambulatory Monitoring Systems with Acquisition
AliveCor, an ECG technology specialist, is going in a bold direction with its newest acquisition. The Mountain View, CA-based company is purchasing CardioLabs, a monitoring and cardiac diagnostic service provider.
9. Google downsizes health division, reorganizes consumer-health team
Google is reportedly shaking things up in its health division. The company is moving more than 130 of its roughly 700 Google Health employees to Search and its new Fitbit group
10. Grail starts selling multi-cancer liquid biopsy Galleri in the US
Grail has begun selling its multi-cancer early detection blood test Galleri in the U.S. to adults with an elevated risk of cancer.
11. Advanced Human Imaging's smartphone-based derma AI gets CE mark
Australian smartphone-based medical imaging company Advanced Human Imaging disclosed last week that it received a CE Mark for the dermatology artificial intelligence component in its DermaScan SaaS platform.
12. FDA grants swift approval to Cognoa’s digital device for autism diagnosis
The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval.